Your browser doesn't support javascript.
loading
Gata3 is detrimental to regulatory T cell function in autoimmune diabetes.
Kiaf, Badr; Bode, Kevin; Schuster, Cornelia; Kissler, Stephan.
  • Kiaf B; Section for Immunobiology, Joslin Diabetes Center, Boston, MA 02215.
  • Bode K; Department of Medicine, Harvard Medical School, Boston MA 02115.
  • Schuster C; Section for Immunobiology, Joslin Diabetes Center, Boston, MA 02215.
  • Kissler S; Department of Medicine, Harvard Medical School, Boston MA 02115.
bioRxiv ; 2023 Mar 23.
Article en En | MEDLINE | ID: mdl-36993342
ABSTRACT
Regulatory T cells (Tregs) protect against autoimmunity. In type 1 diabetes (T1D), Tregs slow the progression of beta cell autoimmunity within pancreatic islets. Increasing the potency or frequency of Tregs can prevent diabetes, as evidenced by studies in the nonobese diabetic (NOD) mouse model for T1D. We report herein that a significant proportion of islets Tregs in NOD mice express Gata3. The expression of Gata3 was correlated with the presence of IL-33, a cytokine known to induce and expand Gata3+ Tregs. Despite significantly increasing the frequency of Tregs in the pancreas, exogenous IL-33 was not protective. Based on these data, we hypothesized that Gata3 is deleterious to Treg function in autoimmune diabetes. To test this notion, we generated NOD mice with a Treg-specific deletion of Gata3. We found that deleting Gata3 in Tregs strongly protected against diabetes. Disease protection was associated with a shift of islet Tregs toward a suppressive CXCR3+Foxp3+ population. Our results suggest that islet Gata3+ Tregs are maladaptive and that this Treg subpopulation compromises the regulation of islet autoimmunity, contributing to diabetes onset.
Palabras clave